Effect of New Specialized Technique Using Effleurage Massage on Striae Gravidarum
EM/SG
The Efficacy of Effleurage Massage on Striae Gravidarum During Pregnancy
1 other identifier
interventional
42
1 country
1
Brief Summary
The goal of this clinical trial is to learn if our new specialized technique using effleurage massage works to prevent striae gravidarum in primigravida. The main questions it aims to answer are: Can our new specialized technique using effleurage massage prevent or even decrease the severity of striae gravidarum in primigravida ? What side effects may participants face when using our technique? Participants will: perform effleurage massage in transverse direction from medial to lateral only not back and forth, twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy for 10 minutes for each time until date of birth but from lateral to medial. It will be performed on the whole abdominal area extending from the diaphragm to the pupic area, also on both sides of the abdomen extending from the 12th rib to the iliac crest.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2025
CompletedFirst Submitted
Initial submission to the registry
November 22, 2025
CompletedFirst Posted
Study publicly available on registry
December 4, 2025
CompletedDecember 4, 2025
November 1, 2025
3 months
November 22, 2025
December 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Reduction in Striae Gravidarum severity
Severity of striae gravidarum will be assessed using INA score at three time points during pregnancy to evaluate progression and response to the intervention
At 21 weeks of gestation, 29 weeks of gestation ,and 39 weeks of gestation
Study Arms (2)
Efficacy of EM on SG
ACTIVE COMPARATOREach patient in this group will perform effleurage massage in transverse direction from medial to lateral only not back and forth, twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy for 10 minutes for each time until date of birth but from lateral to medial. It will be performed on the whole abdominal area extending from the diaphragm to the pupic area, also on both sides of the abdomen extending from the 12th rib to the iliac crest.
Efficacy of olive oil only on SG
ACTIVE COMPARATORThey will apply olive oil only twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy until date of birth .
Interventions
effleurage massage was performed in transverse direction from medial to lateral only not back and forth, twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy for 10 minutes for each time until date of birth but from lateral to medial. It will be performed on the whole abdominal area extending from the diaphragm to the pupic area, also on both sides of the abdomen extending from the 12th rib to the iliac crest.
Eligibility Criteria
You may qualify if:
- All females will be primigravida.
- All females will be at the 17th week to the 20th week of gestation.
- Age of participants will range from 20-30 years.
- Their BMI will not exceed 28 kg/m.
You may not qualify if:
- Any dermal pathology.
- Psychiatric disorders.
- Skin tumor.
- Pregnant with more than one child.
- History or symptoms of premature birth.
- Placental abruption.
- History of abdominal surgeries.
- History of abdominal hernia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Outpatient Clinics, Faculty of Physical Therapy, Kafrelsheikh University, Egypt
Kafr ash Shaykh, Kafr el-Sheikh Governorate, 33511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior physical therapist in physical therapy for woman health Department, Sidi-Salem Hospital, Kafrelsheikh, Egypt
Study Record Dates
First Submitted
November 22, 2025
First Posted
December 4, 2025
Study Start
October 9, 2024
Primary Completion
January 12, 2025
Study Completion
May 30, 2025
Last Updated
December 4, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared. This study involves sensitive participant information and there is no plan for data sharing.